Inhibition of the astrocyte-specific JAK/STAT3 pathway via genetic overexpression of suppressor of cytokine signaling 3 (SOCS3) was shown to prevent astrocyte reactivity and decrease microglial activation in AD animal models [11]. The gene discussed is SOCS3; the disease is Alzheimer disease.